https://sentinelinitiative.org/methods-data-tools/methods/covid-19-pregnancy-study-implementation
COVID-19 Pregnancy Study Implementation
Methods, Data, & Tools
02/24/2021
Methods, Data, & Tools
02/24/2021
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-mothers-mother-infant-linkage-table
Characterization of Mothers in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis
Modular Programs
03/11/2021
Modular Programs
03/11/2021
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2017-first
Duration of Follow Up for New Molecular Entities Approved in 2017: First Descriptive Analysis
Analyses
08/13/2021
Analyses
08/13/2021
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-drugs-approved-risk-evaluation-and-mitigation
Utilization of Drugs with Approved Risk Evaluation and Mitigation Strategies (REMS) That Employ Elements to Assure Safe Use (ETASU)
Assessments
08/23/2021
Assessments
08/23/2021
https://sentinelinitiative.org/news-events/publications-presentations/prescription-medication-use-and-baseline-health-status-women
Prescription Medication Use and Baseline Health Status of Women with Live Birth Deliveries in a National Data Network: The Sentinel Distributed Database Mother-Infant Linkage Table
Publications and Presentations
08/23/2021
Publications and Presentations
08/23/2021
https://sentinelinitiative.org/methods-data-tools/methods/making-medicaid-data-more-accessible-through-common-data-models-and-fhir
Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs
Methods, Data, & Tools
09/24/2021
Methods, Data, & Tools
09/24/2021
https://sentinelinitiative.org/news-events/publications-presentations/prescription-medication-use-and-baseline-health-status-0
Prescription Medication Use and Baseline Health Status of Women with Live Birth Deliveries in a National Data Network
Publications and Presentations
10/14/2021
Publications and Presentations
10/14/2021
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2021-13th-annual-sentinel-initiative-public-workshop
2021 13th Annual Sentinel Initiative Public Workshop
Sentinel Initiative Events
11/08/2021
Sentinel Initiative Events
11/08/2021
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2017-second
Duration of Follow Up for New Molecular Entities Approved in 2017: Second Descriptive Analysis
Analyses
01/21/2022
Analyses
01/21/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2019-first
Duration of Follow Up for New Molecular Entities Approved in 2019: First Descriptive Analysis
Analyses
01/26/2022
Analyses
01/26/2022
https://sentinelinitiative.org/methods-data-tools/methods/augmenting-date-death-cause-death-ascertainment-sentinel
Augmenting Date of Death & Cause of Death Ascertainment in Sentinel
Methods, Data, & Tools
03/16/2022
Methods, Data, & Tools
03/16/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/incident-and-prevalent-use-loop-diuretics-descriptive
Incident and Prevalent Use of Loop Diuretics: A Descriptive Analysis
Analyses
03/23/2022
Analyses
03/23/2022
https://sentinelinitiative.org/engage-sentinel/quarterly-newsletter
Quarterly Newsletter
Spotlight
03/24/2022
Spotlight
03/24/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/epidiolex-prescription-cannabidiol-utilization-patterns
Epidiolex (Prescription Cannabidiol) Utilization Patterns: A Descriptive Analysis
Analyses
03/28/2022
Analyses
03/28/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2018-first
Duration of Follow Up for New Molecular Entities Approved in 2018: First Descriptive Analysis
Analyses
04/20/2022
Analyses
04/20/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/incidence-and-prevalence-confounding-variables-over-time
Incidence and Prevalence of Confounding Variables Over Time in the Sentinel Distributed Database (SDD): A Descriptive Analysis
Analyses
04/21/2022
Analyses
04/21/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/thromboembolic-stroke-major-extracranial-bleeding-0
Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use in Patients Aged 65 or Older: An Inverse Probability of Treatment Weighting (IPTW) Analysis
Analyses
04/25/2022
Analyses
04/25/2022
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2022-sentinel-public-training-day-inverse-probability
2022 Sentinel Public Training Day: Inverse Probability of Treatment Weighting & Innovation DayÂ
Sentinel Initiative Events
04/28/2022
Sentinel Initiative Events
04/28/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-pediatric-demographics-and-enrollment
Characterization of Pediatric Demographics and Enrollment in the Sentinel Distributed Database: A Descriptive Analysis
Analyses
05/16/2022
Analyses
05/16/2022
https://sentinelinitiative.org/methods-data-tools/methods/approaches-handling-partially-observed-confounder-data-electronic-health
Approaches to Handling Partially Observed Confounder Data From Electronic Health Records (EHR) In Non-randomized Studies of Medication Outcomes
Methods, Data, & Tools
06/01/2022
Methods, Data, & Tools
06/01/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-infants-mother-infant-linkage-table
Characterization of Infants in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis
Analyses
06/30/2022
Analyses
06/30/2022
https://sentinelinitiative.org/studies/drugs/women-heart-failure
Women with Heart Failure & Pregnancy
Studies
08/10/2022
Studies
08/10/2022
https://sentinelinitiative.org/news-events/publications-presentations/data-driven-approaches-improve-phenotype-sensitivity-using
Data-Driven Approaches to Improve Phenotype Sensitivity Using EHR Data
Publications and Presentations
08/28/2022
Publications and Presentations
08/28/2022
https://sentinelinitiative.org/news-events/publications-presentations/characterizing-infants-sentinel-distributed-database-mother
Characterizing Infants in the Sentinel Distributed Database Mother-Infant Linkage Table
Publications and Presentations
08/28/2022
Publications and Presentations
08/28/2022
https://sentinelinitiative.org/news-events/publications-presentations/characterizing-pediatric-members-sentinel-distributed
Characterizing Pediatric Members in the Sentinel Distributed Database
Publications and Presentations
08/28/2022
Publications and Presentations
08/28/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-ozempic-use-patients-type-2
Outcome Monitoring Following Ozempic Use in Patients with Type 2 Diabetes: A Signal Identification Analysis
Analyses
11/10/2022
Analyses
11/10/2022
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2022-14th-annual-sentinel-initiative-public-workshop
2022 14th Annual Sentinel Initiative Public Workshop
Sentinel Initiative Events
11/15/2022
Sentinel Initiative Events
11/15/2022
https://sentinelinitiative.org/methods-data-tools/methods/inclusion-semi-structured-and-unstructured-electronic-health-record-ehr
Inclusion of Semi-Structured and Unstructured Electronic Health Record (EHR) Data in Confounding Adjustment and Outcome Ascertainment
Methods, Data, & Tools
12/09/2022
Methods, Data, & Tools
12/09/2022
https://sentinelinitiative.org/methods-data-tools/methods/development-and-evaluation-electronic-health-record-ehr-information
Development and Evaluation of Electronic Health Record (EHR) Information Extraction Pipeline and Tree-Based Scan Statistic (TBSS) Methods for EHR-Based Signal Detection (DA2)
Methods, Data, & Tools
01/27/2023
Methods, Data, & Tools
01/27/2023
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/understanding-use-negative-controls-assess-validity-non
Understanding the Use of Negative Controls to Assess the Validity of Non-Interventional Studies of Treatment Using Real-World Evidence
Sentinel Initiative Events
03/08/2023
Sentinel Initiative Events
03/08/2023
https://sentinelinitiative.org/news-events/publications-presentations/identifying-pediatric-hypertension-real-world-data-comparing
Identifying Pediatric Hypertension in Real World Data: Comparing Two Computable Phenotypes
Publications and Presentations
03/27/2023
Publications and Presentations
03/27/2023
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2023-sentinel-public-training-signal-identification-among
2023 Sentinel Public Training: Signal Identification Among Infants Following Maternal Medication Use During Pregnancy & Innovation Day
Sentinel Initiative Events
04/11/2023
Sentinel Initiative Events
04/11/2023
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/angioedema-following-sacubitrilvalsartan-use-patients-heart
Angioedema Following Sacubitril/Valsartan Use in Patients with Heart Failure: A Propensity Score Analysis
Analyses
04/21/2023
Analyses
04/21/2023
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/angioedema-following-sacubitrilvalsartan-use-patients-0
Angioedema Following Sacubitril/Valsartan Use in Patients with Heart Failure: An Updated Propensity Score Matched Analysis
Analyses
04/21/2023
Analyses
04/21/2023
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-beta-blockers-pediatric-population-descriptive
Utilization of Beta Blockers in the Pediatric Population: A Descriptive Analysis
Analyses
07/19/2023
Analyses
07/19/2023
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-beta-blockers-pediatric-population-updated
Utilization of Beta Blockers in the Pediatric Population: An Updated Descriptive Analysis
Analyses
07/19/2023
Analyses
07/19/2023
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/baloxavir-and-oseltamivir-utilization-descriptive-analysis
Baloxavir and Oseltamivir Utilization: A Descriptive Analysis
Analyses
08/18/2023
Analyses
08/18/2023
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-products-development-pregnancy-safety-study
Utilization of Products for the Development of the Pregnancy Safety Study Framework Among Mothers with Live-Birth Deliveries: A Descriptive Analysis
Analyses
09/15/2023
Analyses
09/15/2023
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-products-development-pregnancy-safety-study-0
Utilization of Products for the Development of the Pregnancy Safety Study Framework Among Mothers Linked to Live-Birth Deliveries in the Mother-Infant Linkage Table: A Descriptive Analysis
Analyses
09/15/2023
Analyses
09/15/2023
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2023-public-workshop-optimizing-use-postapproval-pregnancy
2023 Public Workshop: Optimizing the Use of Postapproval Pregnancy Safety Studies
Sentinel Initiative Events
09/18/2023
Sentinel Initiative Events
09/18/2023
https://sentinelinitiative.org/studies/drugs/aimovig-erenumab-0
Aimovig (Erenumab) & Signal Identification
Studies
10/12/2023
Studies
10/12/2023
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-drugs-approved-risk-evaluation-and-mitigation-0
Utilization of Drugs with Approved Risk Evaluation and Mitigation Strategies (REMS) That Employ Elements to Assure Safe Use (ETASU): A Descriptive Analysis
Analyses
10/18/2023
Analyses
10/18/2023
https://sentinelinitiative.org/methods-data-tools/methods/characterization-covid-19-vaccination-data-sdd-0
Characterization of COVID-19 Vaccination Data in the SDD
Methods, Data, & Tools
10/25/2023
Methods, Data, & Tools
10/25/2023
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2023-15th-annual-sentinel-initiative-public-workshop
2023 15th Annual Sentinel Initiative Public Workshop
Sentinel Initiative Events
11/08/2023
Sentinel Initiative Events
11/08/2023
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/risk-non-cardiac-congenital-malformations-following
Risk of Non-Cardiac Congenital Malformations Following Armodafinil or Modafinil Use: A Propensity Score Matched Analysis
Analyses
11/13/2023
Analyses
11/13/2023
https://sentinelinitiative.org/methods-data-tools/methods/empirical-application-sentinel-electronic-health-record-ehr-and-claims
Empirical Application of the Sentinel Electronic Health Record (EHR) and Claims Data Partner Network to Address ARIA Insufficient Inferential Requests
Methods, Data, & Tools
11/17/2023
Methods, Data, & Tools
11/17/2023
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2024-sentinel-innovation-and-methods-seminar-series
2024 Sentinel Innovation and Methods Seminar Series
Sentinel Initiative Events
01/01/2024
Sentinel Initiative Events
01/01/2024
https://sentinelinitiative.org/methods-data-tools/methods/covid-19-pandemic-related-changes-healthcare-utilization-among-insured
COVID-19 Pandemic Related Changes in Healthcare Utilization Among Insured Persons in the US and its Impact on Pharmacoepidemiologic Research
Methods, Data, & Tools
01/11/2024
Methods, Data, & Tools
01/11/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-baloxavir-use-signal
Outcome Monitoring Following Baloxavir Use: A Signal Identification Analysis
Analyses
01/19/2024
Analyses
01/19/2024
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/coding-trend-analyses-biopsy
Coding Trend Analyses: Biopsy
Methods, Data, & Tools
02/08/2024
Methods, Data, & Tools
02/08/2024
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/coding-trend-analyses-crohns-disease
Coding Trend Analyses: Crohn's Disease
Methods, Data, & Tools
02/08/2024
Methods, Data, & Tools
02/08/2024
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/coding-trend-analyses-colectomy-colostomy-and-ileostomy
Coding Trend Analyses: Colectomy, Colostomy, and Ileostomy
Methods, Data, & Tools
02/08/2024
Methods, Data, & Tools
02/08/2024
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/coding-trend-analyses-diverticulitis-and-colitis
Coding Trend Analyses: Diverticulitis and Colitis
Methods, Data, & Tools
02/08/2024
Methods, Data, & Tools
02/08/2024
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/coding-trend-analyses-endoscopy
Coding Trend Analyses: Endoscopy
Methods, Data, & Tools
02/08/2024
Methods, Data, & Tools
02/08/2024
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/coding-trend-analyses-ulcerative-colitis
Coding Trend Analyses: Ulcerative Colitis
Methods, Data, & Tools
02/08/2024
Methods, Data, & Tools
02/08/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-dupilumab-use-signal
Outcome Monitoring Following Dupilumab Use: A Signal Identification Analysis
Analyses
02/15/2024
Analyses
02/15/2024
https://sentinelinitiative.org/studies/drugs/provigil-modafinil-and-nuvigil-armodafinil-0
Provigil (Modafinil) and Nuvigil (Armodafinil) & Congenital Cardiac and Non-Cardiac Malformations
Studies
02/22/2024
Studies
02/22/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/occurrence-stroke-intracranial-hemorrhage-and-bleeding
Occurrence of Stroke, Intracranial Hemorrhage, and Bleeding Outcomes Following Direct Oral Anticoagulant Use in Patients Aged 64 or Younger with Atrial Fibrillation: A Descriptive Analysis
Analyses
03/04/2024
Analyses
03/04/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/intentional-self-harm-following-montelukast-use-patients
Intentional Self-Harm Following Montelukast Use in Patients with Asthma: An Updated Analysis Using ICD-10-CM Coding
Analyses
03/21/2024
Analyses
03/21/2024
https://sentinelinitiative.org/studies/drugs/singulair-montelukast-0
Singulair (Montelukast) & Intentional Self-Harm
Studies
03/21/2024
Studies
03/21/2024
https://sentinelinitiative.org/news-events/publications-presentations/targeted-learning-undersmoothed-lasso-propensity-score-model
Targeted Learning with an Undersmoothed Lasso Propensity Score Model for Large-Scale Covariate Adjustment in Healthcare Database Studies
Publications and Presentations
03/21/2024
Publications and Presentations
03/21/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-loop-diuretics-descriptive-analysis
Utilization of Loop Diuretics: A Descriptive Analysis
Analyses
04/12/2024
Analyses
04/12/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-products-over-time-development-pregnancy-safety
Utilization of Products Over Time for the Development of the Pregnancy Safety Study Framework Among Mothers with Live-Birth Deliveries: A Descriptive Analysis
Analyses
04/19/2024
Analyses
04/19/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/hydrochlorothiazide-use-following-labeling-update-include-0
Hydrochlorothiazide Use Following Labeling Update to Include the Risk of Non-Melanoma Skin Cancer: An Interrupted Time Series Analysis
Analyses
04/23/2024
Analyses
04/23/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/interstitial-lung-disease-ild-patients-inflammatory-bowel
Interstitial Lung Disease (ILD) in Patients with Inflammatory Bowel Disease (IBD) and Following Vedolizumab or Natalizumab Initiation: A Descriptive Analysis
Analyses
05/09/2024
Analyses
05/09/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/interstitial-lung-disease-ild-rates-patients-inflammatory
Interstitial Lung Disease (ILD) Rates in Patients with Inflammatory Bowel Disease (IBD) and Following IBD Advanced Therapy: A Descriptive Analysis
Analyses
05/09/2024
Analyses
05/09/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/concomitant-use-medications-drug-drug-interactions
Concomitant Use of Medications with Drug-Drug Interactions with Nirmatrelvir and Ritonavir Among Patients Treated with Nirmatrelvir and Ritonavir or Patients with COVID-19: A Descriptive Analysis
Analyses
05/17/2024
Analyses
05/17/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-beta-blockers-pediatric-population-follow
Utilization of Beta Blockers in the Pediatric Population: A Follow Up Updated Descriptive Analysis
Analyses
05/20/2024
Analyses
05/20/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-pediatric-demographics-and-enrollment-0
Characterization of Pediatric Demographics and Enrollment in the Sentinel Distributed Database: An Updated Descriptive Analysis
Analyses
06/10/2024
Analyses
06/10/2024
https://sentinelinitiative.org/studies/drugs/angiotensin-converting-enzyme-ace-inhibitors-and-angiotensin-ii-receptor-blockers-0
Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin II Receptor Blockers (ARBs) & Pediatric Drug Utilization
Studies
06/13/2024
Studies
06/13/2024
https://sentinelinitiative.org/news-events/publications-presentations/triple-challenges-small-sample-size-both-exposure-and
Triple Challenges – Small Sample Size in Both Exposure and Control Groups to Scan Rare Maternal Outcomes in a Signal Identification Approach: A Simulation Study
Publications and Presentations
06/24/2024
Publications and Presentations
06/24/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/serious-infection-following-ustekinumab-use-patients-crohn-0
Serious Infection Following Ustekinumab Use in Patients with Crohn’s Disease: An Inverse Probability of Treatment Weighting Analysis
Analyses
06/24/2024
Analyses
06/24/2024
https://sentinelinitiative.org/studies/drugs/xofluza-baloxavir
Xofluza (Baloxavir) & Signal Identification
Studies
06/25/2024
Studies
06/25/2024
https://sentinelinitiative.org/news-events/publications-presentations/use-sentinel-system-examine-medical-product-use-and-outcomes
Use of the Sentinel System to Examine Medical Product Use and Outcomes During Pregnancy
Publications and Presentations
06/28/2024
Publications and Presentations
06/28/2024
https://sentinelinitiative.org/methods-data-tools/software-packages-toolkits/centers-medicare-and-medicaid-services-cms-medicaid
The Centers for Medicare and Medicaid Services (CMS): Medicaid and Children’s Health Insurance Program (CHIP) Claims in Sentinel Common Data Model (SCDM) Format
Methods, Data, & Tools
07/02/2024
Methods, Data, & Tools
07/02/2024
https://sentinelinitiative.org/news-events/publications-presentations/simple-cox-approach-estimating-risk-ratios-without-sharing
A Simple Cox Approach to Estimating Risk Ratios Without Sharing Individual-Level Data in Multi-Site Studies
Publications and Presentations
07/05/2024
Publications and Presentations
07/05/2024
https://sentinelinitiative.org/news-events/publications-presentations/distributed-regression-analysis-application-package-using
A Distributed Regression Analysis Application Package Using SAS
Publications and Presentations
07/09/2024
Publications and Presentations
07/09/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/counts-and-characteristics-dipeptidyl-peptidase-4-dpp-4
Counts and Characteristics of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor or Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitor Users with Type 2 Diabetes: A Descriptive Analysis
Analyses
07/11/2024
Analyses
07/11/2024
https://sentinelinitiative.org/news-events/publications-presentations/future-data-rich-pharmacoepidemiology-studies-transitioning
A Future of Data-Rich Pharmacoepidemiology Studies - Transitioning to Large-Scale Linked EHR+Claims Data
Publications and Presentations
07/16/2024
Publications and Presentations
07/16/2024
https://sentinelinitiative.org/studies/drugs/brexafemme-ibrexafungerp
Brexafemme (Ibrexafungerp) & Use in Pregnancy
Studies
07/17/2024
Studies
07/17/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-ibrexafungerp-pregnant-patients-updated-0
Utilization of Ibrexafungerp in Pregnant Patients: An Updated Descriptive Analysis
Analyses
07/17/2024
Analyses
07/17/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-methotrexate-descriptive-analysis-trinetx
Utilization of Methotrexate: A Descriptive Analysis in TriNetX
Analyses
07/17/2024
Analyses
07/17/2024
https://sentinelinitiative.org/studies/drugs/glucagon-peptide-1-receptor-agonists
Glucagon-Like Peptide-1 Receptor Agonists & Intentional Self-Harm
Studies
07/22/2024
Studies
07/22/2024
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/intentional-self-harm-algorithm-defined-intentional-2
Intentional Self-Harm Algorithm Defined in "Intentional Self-Harm Following Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) Use in Patients with Obesity: A Descriptive Analysis"
Methods, Data, & Tools
07/22/2024
Methods, Data, & Tools
07/22/2024
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/intentional-self-harm-algorithm-defined-intentional-1
Intentional Self-Harm Algorithm Defined in "Intentional Self-Harm Following Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) Use in Patients with Diabetes: An Inverse Probability of Treatment Weighting Analysis"
Methods, Data, & Tools
07/22/2024
Methods, Data, & Tools
07/22/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/intentional-self-harm-following-glucagon-peptide-1-receptor
Intentional Self-Harm Following Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) Use in Patients with Diabetes: An Inverse Probability of Treatment Weighting Analysis
Analyses
07/22/2024
Analyses
07/22/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/intentional-self-harm-following-glucagon-peptide-1-0
Intentional Self-Harm Following Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) Use in Patients with Obesity: A Descriptive Analysis
Analyses
07/22/2024
Analyses
07/22/2024
https://sentinelinitiative.org/studies/drugs/drugs-risk-evaluation-and-mitigation-strategies-rems-employ-elements-assure-safe-use
Drugs with Risk Evaluation and Mitigation Strategies (REMS) That Employ Elements to Assure Safe Use (ETASU) & Utilization
Studies
07/23/2024
Studies
07/23/2024
https://sentinelinitiative.org/news-events/publications-presentations/research-action-podcast-transforming-public-health
Research in Action Podcast: Transforming Public Health with Unstructured Data and NLP in FDA's Sentinel Initiative
Publications and Presentations
07/23/2024
Publications and Presentations
07/23/2024
https://sentinelinitiative.org/news-events/publications-presentations/identifying-pediatric-hypertension-observational-data
Identifying Pediatric Hypertension in Observational Data: Comparing Clinical and Claims Cohorts in Real World Data
Publications and Presentations
07/24/2024
Publications and Presentations
07/24/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/prevalence-selected-conditions-among-individuals
Prevalence of Selected Conditions Among Individuals with Childbearing Potential: A Descriptive Analysis
Analyses
07/26/2024
Analyses
07/26/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2017-third
Duration of Follow Up for New Molecular Entities Approved in 2017: Third Descriptive Analysis
Analyses
07/30/2024
Analyses
07/30/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2018-second
Duration of Follow Up for New Molecular Entities Approved in 2018: Second Descriptive Analysis
Analyses
07/30/2024
Analyses
07/30/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2019-second
Duration of Follow Up for New Molecular Entities Approved in 2019: Second Descriptive Analysis
Analyses
07/30/2024
Analyses
07/30/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2020-first
Duration of Follow Up for New Molecular Entities Approved in 2020: First Descriptive Analysis
Analyses
07/30/2024
Analyses
07/30/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2021-first
Duration of Follow Up for New Molecular Entities Approved in 2021: First Descriptive Analysis
Analyses
07/30/2024
Analyses
07/30/2024
https://sentinelinitiative.org/studies/drugs/new-molecular-entities-nmes
New Molecular Entities (NMEs) & Utilization Characterization
Studies
07/30/2024
Studies
07/30/2024
https://sentinelinitiative.org/methods-data-tools/routine-querying-tools/sentinel-routine-querying-system
Sentinel Routine Querying System
Methods, Data, & Tools
07/30/2024
Methods, Data, & Tools
07/30/2024
https://sentinelinitiative.org/methods-data-tools/routine-querying-tools/sentinel-routine-querying-system-reporting-tool
Sentinel Routine Querying System Reporting Tool
Methods, Data, & Tools
07/30/2024
Methods, Data, & Tools
07/30/2024
https://sentinelinitiative.org/studies/drugs/dupixent-dupilumab
Dupixent (Dupilumab) & Signal Identification
Studies
07/31/2024
Studies
07/31/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-dupilumab-descriptive-analysis
Utilization of Dupilumab: A Descriptive Analysis
Assessments
07/31/2024
Assessments
07/31/2024
https://sentinelinitiative.org/methods-data-tools/software-packages-toolkits/sentinel-views
Sentinel Views
Methods, Data, & Tools
07/31/2024
Methods, Data, & Tools
07/31/2024
https://sentinelinitiative.org/studies/drugs/confounding-conditions
Confounding Conditions & Characterization
Studies
08/01/2024
Studies
08/01/2024
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/covid-19-severity-algorithm-defined-risk-adverse
COVID-19 Severity Algorithm Defined in "Risk of Adverse Neonatal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis"
Methods, Data, & Tools
08/02/2024
Methods, Data, & Tools
08/02/2024
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/low-birth-weight-algorithm-defined-risk-adverse
Low Birth Weight Algorithm Defined in "Risk of Adverse Neonatal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis"
Methods, Data, & Tools
08/02/2024
Methods, Data, & Tools
08/02/2024
https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/lumisight-pegulicianine
Assessment of ARIA Sufficiency: Lumisight (pegulicianine)
Sufficiency Assessments
08/02/2024
Sufficiency Assessments
08/02/2024
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/major-congenital-malformation-algorithm-defined-risk
Major Congenital Malformation Algorithm Defined in "Risk of Adverse Neonatal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis"
Methods, Data, & Tools
08/02/2024
Methods, Data, & Tools
08/02/2024
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/microcephaly-algorithm-defined-risk-adverse-neonatal
Microcephaly Algorithm Defined in "Risk of Adverse Neonatal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis"
Methods, Data, & Tools
08/02/2024
Methods, Data, & Tools
08/02/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/risk-adverse-neonatal-health-outcomes-among-pregnant
Risk of Adverse Neonatal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis
Analyses
08/02/2024
Analyses
08/02/2024
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/small-gestational-age-algorithm-defined-risk-adverse
Small for Gestational Age Algorithm Defined in "Risk of Adverse Neonatal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis"
Methods, Data, & Tools
08/02/2024
Methods, Data, & Tools
08/02/2024
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/overview-cder-s-real-world-evidence-demonstration-projects
Overview of CDER’s Real-World Evidence Demonstration Projects
Sentinel Initiative Events
08/05/2024
Sentinel Initiative Events
08/05/2024
https://sentinelinitiative.org/studies/drugs/pediatric-patients-0
Pediatric Patients & Characterization
Studies
08/06/2024
Studies
08/06/2024
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/caesarean-section-algorithm-defined-risk-adverse
Caesarean Section Algorithm Defined in "Risk of Adverse Maternal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis"
Methods, Data, & Tools
08/07/2024
Methods, Data, & Tools
08/07/2024
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/covid-19-severity-algorithm-defined-risk-adverse-0
COVID-19 Severity Algorithm Defined in "Risk of Adverse Maternal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis"
Methods, Data, & Tools
08/07/2024
Methods, Data, & Tools
08/07/2024
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/gestational-diabetes-mellitus-algorithm-defined-risk
Gestational Diabetes Mellitus Algorithm Defined in "Risk of Adverse Maternal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis"
Methods, Data, & Tools
08/07/2024
Methods, Data, & Tools
08/07/2024
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/maternal-death-algorithm-defined-risk-adverse-maternal
Maternal Death Algorithm Defined in "Risk of Adverse Maternal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis"
Methods, Data, & Tools
08/07/2024
Methods, Data, & Tools
08/07/2024
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/preeclampsia-algorithm-defined-risk-adverse-maternal
Preeclampsia Algorithm Defined in "Risk of Adverse Maternal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis"
Methods, Data, & Tools
08/07/2024
Methods, Data, & Tools
08/07/2024
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/preterm-birth-algorithm-defined-risk-adverse-maternal
Preterm Birth Algorithm Defined in "Risk of Adverse Maternal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis"
Methods, Data, & Tools
08/07/2024
Methods, Data, & Tools
08/07/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/risk-adverse-maternal-health-outcomes-among-pregnant
Risk of Adverse Maternal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis
Analyses
08/07/2024
Analyses
08/07/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characteristics-and-drug-utilization-pregnant-patients-covid
Characteristics and Drug Utilization in Pregnant Patients With COVID-19: A Propensity Score Matched Analysis
Analyses
08/08/2024
Analyses
08/08/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-infants-mother-infant-linkage-table-0
Characterization of Infants in the Mother-Infant Linkage Table in the Sentinel Distributed Database: An Updated Descriptive Analysis
Analyses
08/09/2024
Analyses
08/09/2024
https://sentinelinitiative.org/studies/drugs/makena-hydroxyprogesterone-caproate-injection-and-its-generics
Makena (Hydroxyprogesterone Caproate Injection) and Its Generics & Use in Pregnancy
Studies
08/12/2024
Studies
08/12/2024
https://sentinelinitiative.org/studies/drugs/pediatric-patients
Pediatric Patients & Hypertension
Studies
08/16/2024
Studies
08/16/2024
https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/kisunla-donanemab-azbt
Assessment of ARIA Sufficiency: Kisunla (donanemab-azbt)
Sufficiency Assessments
08/20/2024
Sufficiency Assessments
08/20/2024
https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/rinvoq-upadacitinib-0
Assessment of ARIA Sufficiency: Rinvoq (upadacitinib)
Sufficiency Assessments
08/20/2024
Sufficiency Assessments
08/20/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characteristics-and-drug-utilization-dabigatran-rivaroxaban
Characteristics and Drug Utilization in Dabigatran, Rivaroxaban, and Apixaban Initiators Aged 64 or Younger: A Descriptive Analysis
Analyses
08/21/2024
Analyses
08/21/2024
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/gastrointestinal-bleeding-algorithm-defined-1
Gastrointestinal Bleeding Algorithm Defined in "Thromboembolic Stroke, Intracranial Hemorrhage, Gastrointestinal Bleeding, and Major Extracranial Bleeding Following Apixaban, Dabigatran, and Rivaroxaban Use in Patients Aged 64 Years and Younger with Atrial Fibrillation: An Inverse Probability of Treatment Weighting Analysis"
Methods, Data, & Tools
08/21/2024
Methods, Data, & Tools
08/21/2024
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/intracranial-hemorrhage-algorithm-defined-2
Intracranial Hemorrhage Algorithm Defined in "Thromboembolic Stroke, Intracranial Hemorrhage, Gastrointestinal Bleeding, and Major Extracranial Bleeding Following Apixaban, Dabigatran, and Rivaroxaban Use in Patients Aged 64 Years and Younger with Atrial Fibrillation: An Inverse Probability of Treatment Weighting Analysis"
Methods, Data, & Tools
08/21/2024
Methods, Data, & Tools
08/21/2024
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/major-extracranial-bleeding-algorithm-defined-2
Major Extracranial Bleeding Algorithm Defined in "Thromboembolic Stroke, Intracranial Hemorrhage, Gastrointestinal Bleeding, and Major Extracranial Bleeding Following Apixaban, Dabigatran, and Rivaroxaban Use in Patients Aged 64 Years and Younger with Atrial Fibrillation: An Inverse Probability of Treatment Weighting Analysis"
Methods, Data, & Tools
08/21/2024
Methods, Data, & Tools
08/21/2024
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/thromboembolic-stroke-algorithm-defined-2
Thromboembolic Stroke Algorithm Defined in "Thromboembolic Stroke, Intracranial Hemorrhage, Gastrointestinal Bleeding, and Major Extracranial Bleeding Following Apixaban, Dabigatran, and Rivaroxaban Use in Patients Aged 64 Years and Younger with Atrial Fibrillation: An Inverse Probability of Treatment Weighting Analysis"
Methods, Data, & Tools
08/21/2024
Methods, Data, & Tools
08/21/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/thromboembolic-stroke-intracranial-hemorrhage-0
Thromboembolic Stroke, Intracranial Hemorrhage, Gastrointestinal Bleeding, and Major Extracranial Bleeding Following Apixaban, Dabigatran, and Rivaroxaban Use in Patients Aged 64 Years and Younger with Atrial Fibrillation: An Inverse Probability of Treatment Weighting Analysis
Analyses
08/21/2024
Analyses
08/21/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/trends-healthcare-utilization-during-covid-19-pandemic
Trends in Healthcare Utilization During the COVID-19 Pandemic: A Propensity Score Matched and Stratified Analysis
Analyses
08/21/2024
Analyses
08/21/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/trends-healthcare-utilization-during-covid-19-pandemic-0
Trends in Healthcare Utilization During the COVID-19 Pandemic: A Follow Up Propensity Score Matched and Stratified Analysis
Analyses
08/21/2024
Analyses
08/21/2024
https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/iqirvo-elafibranor
Assessment of ARIA Sufficiency: Iqirvo (elafibranor)
Sufficiency Assessments
08/21/2024
Sufficiency Assessments
08/21/2024
https://sentinelinitiative.org/studies/drugs/trends-healthcare-utilization-during-covid-19-pandemic
Trends in Healthcare Utilization During the COVID-19 Pandemic
Studies
08/21/2024
Studies
08/21/2024
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2024-ispe-annual-meeting
2024 ISPE Annual Meeting
Sentinel Initiative Events
08/24/2024
Sentinel Initiative Events
08/24/2024
https://sentinelinitiative.org/news-events/publications-presentations/use-hydrochlorothiazide-united-states-following-label-update
Use of Hydrochlorothiazide in the United States Following Label Update About Skin Cancer Risk
Publications and Presentations
08/26/2024
Publications and Presentations
08/26/2024
https://sentinelinitiative.org/studies/drugs/hydrochlorothiazide-1
Hydrochlorothiazide & Utilization
Studies
08/26/2024
Studies
08/26/2024
https://sentinelinitiative.org/news-events/publications-presentations/covid-19-related-changes-healthcare-utilization-among
COVID-19 Related Changes in Healthcare Utilization Among Insured Persons in the U.S. and its Impact on Pharmacoepidemiologic Research
Publications and Presentations
08/26/2024
Publications and Presentations
08/26/2024
https://sentinelinitiative.org/news-events/publications-presentations/analysis-new-molecular-entity-utilization-patterns-using
Analysis of New Molecular Entity Utilization Patterns using the Sentinel Distributed Database
Publications and Presentations
08/26/2024
Publications and Presentations
08/26/2024
https://sentinelinitiative.org/news-events/publications-presentations/untangling-national-medicaid-data-30-data-quality-metrics
Untangling National Medicaid Data: 30 Data Quality Metrics to Support Maternal Health Studies in Two Common Data Models
Publications and Presentations
08/26/2024
Publications and Presentations
08/26/2024
https://sentinelinitiative.org/news-events/publications-presentations/comparative-postmarketing-safety-assessment-baloxavir
Comparative Postmarketing Safety Assessment of Baloxavir Marboxil vs Oseltamivir Using TreeScan
Publications and Presentations
08/26/2024
Publications and Presentations
08/26/2024
https://sentinelinitiative.org/news-events/publications-presentations/advancing-drug-safety-signal-management-through-multimodal
Advancing Drug Safety Signal Management through Multimodal Approaches in Networking
Publications and Presentations
08/26/2024
Publications and Presentations
08/26/2024
https://sentinelinitiative.org/news-events/publications-presentations/natural-language-processing-pharmacoepidemiology-lessons
Natural Language Processing in Pharmacoepidemiology: Lessons from the Multi-Source Observational Safety study for Advanced Information Classification Using NLP (MOSAIC-NLP)
Publications and Presentations
08/26/2024
Publications and Presentations
08/26/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/hydrochlorothiazide-use-following-labeling-update-include-1
Hydrochlorothiazide Use Following Labeling Update to Include the Risk of Non-Melanoma Skin Cancer: An Updated Interrupted Time Series Analysis
Analyses
08/26/2024
Analyses
08/26/2024
https://sentinelinitiative.org/news-events/publications-presentations/risk-incident-inflammatory-bowel-disease-new-users
Risk of Incident Inflammatory Bowel Disease in New Users of Dipeptidyl Peptidase 4 Inhibitors and Sodium-Dependent Glucose Co-Transporter 2 Inhibitors in the FDA Sentinel System
Publications and Presentations
08/27/2024
Publications and Presentations
08/27/2024
https://sentinelinitiative.org/studies/drugs/interrupted-time-series
Interrupted Time Series & Use Case Testing
Studies
08/27/2024
Studies
08/27/2024
https://sentinelinitiative.org/news-events/publications-presentations/analysis-medicinal-product-utilization-data-fda-sentinel
Analysis of Medicinal Product Utilization Data in the FDA Sentinel System to Inform the Development of a Pregnancy Safety Study FrameworkÂ
Publications and Presentations
08/27/2024
Publications and Presentations
08/27/2024
https://sentinelinitiative.org/news-events/publications-presentations/pediatric-utilization-new-molecular-entities-nmes-summary
Pediatric Utilization of New Molecular Entities (NMEs): A Summary of Early Post-Marketing Uptake in the Sentinel Distributed Database
Publications and Presentations
08/27/2024
Publications and Presentations
08/27/2024
https://sentinelinitiative.org/news-events/publications-presentations/comparing-risk-adverse-infant-outcomes-among-pregnancies-and
Comparing the Risk of Adverse Infant Outcomes Among Pregnancies with and without COVID-19 in the Sentinel System
Publications and Presentations
08/27/2024
Publications and Presentations
08/27/2024
https://sentinelinitiative.org/news-events/publications-presentations/methodological-advances-regulatory-real-world-evidence
Methodological Advances in Regulatory Real World Evidence Generation Systems: Perspectives from Sentinel and DARWIN-EU
Publications and Presentations
08/27/2024
Publications and Presentations
08/27/2024
https://sentinelinitiative.org/news-events/publications-presentations/high-dimensional-multiple-imputation-hdmi-strategies
High-Dimensional Multiple Imputation (hdMI) Strategies for Partially Observed Confounders with Structured and Natural Language Processing-Derived Auxiliary Covariates
Publications and Presentations
08/27/2024
Publications and Presentations
08/27/2024
https://sentinelinitiative.org/news-events/publications-presentations/predicting-causes-death-structured-electronic-health-records
Predicting Causes of Death from Structured Electronic Health Records Using Machine Learning
Publications and Presentations
08/27/2024
Publications and Presentations
08/27/2024
https://sentinelinitiative.org/news-events/publications-presentations/prevalence-selected-health-conditions-among-individuals
Prevalence of Selected Health Conditions among Individuals with Childbearing Potential to Inform the Development of the Pregnancy Safety Study Framework
Publications and Presentations
08/27/2024
Publications and Presentations
08/27/2024
https://sentinelinitiative.org/news-events/publications-presentations/patterns-prescribing-and-dispensing-medicines-among-non
Patterns of Prescribing and Dispensing Medicines Among Non-Hospitalized Pregnant Women with COVID-19: a Prospective Meta-Analysis Pooling Findings from Healthcare Databases in Europe and North America
Publications and Presentations
08/27/2024
Publications and Presentations
08/27/2024
https://sentinelinitiative.org/news-events/publications-presentations/assessment-non-cardiac-congenital-malformations-and-utero
Assessment of Non-Cardiac Congenital Malformations and in Utero Exposure to Modafinil/Armodafinil in the Sentinel Distributed Database
Publications and Presentations
08/27/2024
Publications and Presentations
08/27/2024
https://sentinelinitiative.org/news-events/publications-presentations/prenatal-syphilis-us-characterizing-screening-and-treatment
Prenatal Syphilis in the US: Characterizing Screening and Treatment During Pregnancy in Publicly and Commercially Insured Individuals
Publications and Presentations
08/27/2024
Publications and Presentations
08/27/2024
https://sentinelinitiative.org/news-events/publications-presentations/beta-blocker-associated-hypoglycemia-pediatric-patients
Beta-Blocker-Associated Hypoglycemia in Pediatric Patients: Findings from the FDA Adverse Event Reporting System, National Poison Data System, Medical Literature, and Sentinel Distributed Database
Publications and Presentations
08/28/2024
Publications and Presentations
08/28/2024
https://sentinelinitiative.org/news-events/publications-presentations/characterizing-inpatient-electronic-health-records-ehr-large
Characterizing Inpatient Electronic Health Records (EHR) from a Large Hospital Network for Use in Neonatal Pharmacoepidemiology Studies in the United States
Publications and Presentations
08/28/2024
Publications and Presentations
08/28/2024
https://sentinelinitiative.org/news-events/publications-presentations/characterizing-infants-sentinel-distributed-database-0
Characterizing Infants in the Sentinel Distributed Database Mother-Infant Linkage Table
Publications and Presentations
08/28/2024
Publications and Presentations
08/28/2024
https://sentinelinitiative.org/news-events/publications-presentations/assessing-exposure-recently-approved-medications-inform
Assessing Exposure to Recently Approved Medications to Inform Feasibility for Signal Identification Analyses in the FDA’s Sentinel System
Publications and Presentations
08/28/2024
Publications and Presentations
08/28/2024
https://sentinelinitiative.org/news-events/publications-presentations/comparative-bleeding-risks-among-noac-users-nonvalvular
Comparative Bleeding Risks Among NOAC Users for Nonvalvular Atrial Fibrillation Aged <65 years in the Sentinel System
Publications and Presentations
08/28/2024
Publications and Presentations
08/28/2024
https://sentinelinitiative.org/news-events/publications-presentations/characterizing-pediatric-members-sentinel-distributed-0
Characterizing Pediatric Members in the Sentinel Distributed Database: An Update with Data from Medicaid
Publications and Presentations
08/28/2024
Publications and Presentations
08/28/2024
https://sentinelinitiative.org/news-events/publications-presentations/characterization-covid-19-vaccine-data-sentinel-system
Characterization of COVID-19 Vaccine Data in the Sentinel System
Publications and Presentations
08/28/2024
Publications and Presentations
08/28/2024
https://sentinelinitiative.org/news-events/publications-presentations/tree-based-mining-real-world-data-potential-safety-signals
Tree-Based Mining of Real-World Data for Potential Safety Signals Associated with the Use of Dupilumab in the United States (2017-2023)
Publications and Presentations
08/28/2024
Publications and Presentations
08/28/2024
https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/piasky-crovalimab-akkz-0
Assessment of ARIA Sufficiency: Piasky (crovalimab-akkz)
Sufficiency Assessments
08/30/2024
Sufficiency Assessments
08/30/2024
https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/jesduvroq-daprodustat
Assessment of ARIA Sufficiency: Jesduvroq (daprodustat)
Sufficiency Assessments
08/30/2024
Sufficiency Assessments
08/30/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/counts-and-characteristics-individuals-prurigo-nodularis-and
Counts and Characteristics of Individuals with Prurigo Nodularis and Other Dermatologic Conditions: A Descriptive Analysis
Analyses
09/03/2024
Analyses
09/03/2024
https://sentinelinitiative.org/studies/drugs/immunosuppressive-medications
Immunosuppressive Medications & Duration of Follow-Up
Analyses
09/09/2024
Analyses
09/09/2024
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/assessing-treatment-effects-observational-data-missing
Assessing Treatment Effects in Observational Data with Missing Confounders: A Comparative Study of Practical Doubly-Robust and Traditional Missing Data Methods
Sentinel Initiative Events
09/10/2024
Sentinel Initiative Events
09/10/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-guselkumab-use-signal
Outcome Monitoring Following Guselkumab Use: A Signal Identification Analysis
Analyses
09/17/2024
Analyses
09/17/2024
https://sentinelinitiative.org/studies/drugs/tremfya-guselkumab-0
Tremfya (Guselkumab) & Signal Identification
Studies
09/17/2024
Studies
09/17/2024
https://sentinelinitiative.org/news-events/publications-presentations/exposure-valsartan-products-containing-nitrosamine
Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark
Publications and Presentations
09/18/2024
Publications and Presentations
09/18/2024
https://sentinelinitiative.org/studies/drugs/entyvio-vedolizumab-and-tysabri-natalizumab
Entyvio (Vedolizumab) and Tysabri (Natalizumab) & Interstitial Lung Disease
Studies
09/19/2024
Studies
09/19/2024
https://sentinelinitiative.org/studies/drugs/bumex-bumetanide
Bumex (Bumetanide) & Nitrosamine Impurity
Studies
09/24/2024
Studies
09/24/2024
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/regional-health-information-exchanges-critical-national
Regional Health Information Exchanges as Critical National Infrastructure: Supporting Federal Agency Missions
Sentinel Initiative Events
09/25/2024
Sentinel Initiative Events
09/25/2024
https://sentinelinitiative.org/studies/drugs/skyrizi-risankizumab-rzaa
Skyrizi (Risankizumab-Rzaa) & Signal Identification
Studies
10/01/2024
Studies
10/01/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-risankizumab-use-supplemental
Outcome Monitoring Following Risankizumab Use: A Supplemental Signal Identification Analysis
Analyses
10/01/2024
Analyses
10/01/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-risankizumab-use-signal
Outcome Monitoring Following Risankizumab Use: A Signal Identification Analysis
Analyses
10/01/2024
Analyses
10/01/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-products-labeling-changes-related-pregnancy
Utilization of Products with Labeling Changes Related to Pregnancy Among Mothers with Live-Birth Deliveries: A Descriptive Analysis
Analyses
10/02/2024
Analyses
10/02/2024
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2024-16th-annual-sentinel-initiative-public-workshop
2024 16th Annual Sentinel Initiative Public Workshop
Sentinel Initiative Events
11/07/2024
Sentinel Initiative Events
11/07/2024